Wound Care Biologics Market Report- Industry Sales Data, Size, Growth Rate, SWOT Analysis- By Product(Biologic Skin Substitutes, Growth Factors, Enzyme-Based Formulations), By Application(Acute & Chronic Wounds), By End Users

Wound Care Biologics Market in the Global Industry Landscape

Wound care biologics is a process of healing a wound using active biological agents intended to re-establish innate repair mechanisms, such as plant derived antioxidants, anti-inflammatory biomolecule or antimicrobial properties. Moreover they also facilitate the autolytic debridement of the wound. The chronic wounds cases globally is rising at a rate of 12% annually. Thus the growth in number of cases of severe wounds such as foot ulcers, fire burns and other coupled with the advancing technologies in biologics are driving the growth of global wound care biologics market. Moreover, the high cost treatment of wound care is an essential factor pushing the R&D to decrease the cost of treatment and making it easily available. Further, Sulbogin ointment for wound dressing is a FDA approved medicine most effective for treatment of chronic wounds. Many wound care biologic medicines are under clinical trials such as thymol, α-terpineol, genipin, aucubin and more.

Our Global Wound Care Biologics Market can be segmented on the following basis:

Based on Product Type

• Biologic Skin Substitutes
• Growth Factors
• Enzyme Based Formulations

Based on Application

• Acute Wounds
• Chronic Wounds

Based on End Users 

• Hospitals
• Clinics
• Surgical Centers
• Home Care Settings

Based on Geography

• North America (U.S. & Canada)  Wound Care Biologics Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest Of Latin America) Wound Care Biologics  Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe) Wound Care Biologics Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia) Wound Care Biologics Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, Romea) Wound Care Biologics  Market {Market Share (%), Market Size (USD Billion)}

Global Wound Care Biologics Market Outlook comprises of the following data:

• Wound care biologics market size and market compounded annual growth rate, 2017-2025
• Wound care biologics market share by product type, application and end users, 2017-2025
• Sales and Revenue of wound care biologics market, by players, 2017-18
• Sales and Revenue of wound care biologics market, by region, 2017-18

In 2017 on the basis of end users, Hospitals accounted for largest market share followed by surgical centers. Hospitals have huge demand for wound care biologics owing to the fact that patients primarily tends to visit hospitals for the treatment and then further referred to the surgical centers.

New Technologies: The Company Histogen, Inc., has come out with new wound care product Exceltrix that offers to heal wounds with less agonizing and without any infections and scars in the process of healing. The technology used is the proprietary bioreactor that leads to growth of newborn cells on beads suspended in liquid under low-oxygen (hypoxic) conditions. The bioreactor uses 3-5% oxygen (instead of 21% oxygen in air we breathe) for the growth of cells.

Expert Analysis: Wound care biologics are is largely focused by the various global companies and organizations and is undergoing intensive research to bring out new products to cure or decrease the severity of wounds. An example is the negative pressure wound therapy that has changed wound care perspective and has proven beneficial for a variety of wounds. Also the Hydroconductive dressings are another emerging category with studies underway. Moreover various factors such as hyperbaric oxygen, skin substitutes, biologic dressings, and regenerative materials tends to highlight the wound care mechanisms and thus thrusting the growth of global wound care biologics market.